In September 2025, the Russian Federal Medical and Biological Agency announced that its mRNA-based vaccine Enteromix had ...
A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, ...
The link between Covid jabs and cancer has previously been dismissed by academics and oncologists after claims it had led to ...
A dismantled health infrastructure leaves the U.S. incredibly vulnerable, warns infectious-disease expert Michael Osterholm.
An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...
A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, ...
Learn about an exciting new mRNA vaccine that could prevent a wide variety of allergies, and even help those with asthma and ...
President Yoweri Museveni has indicated that the Ugandan economy will reap big from the knowledge economy, that includes ...
Major changes are underway at the Centers for Disease Control and Prevention (CDC) following dismissal of director Susan ...
Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of ...
TipRanks on MSN

VOO ETF News, 9/29/2025

How is VOO stock faring? The Vanguard S&P 500 ETF is down 0.14% in the past five days but up 13.98% year-to-date. According to TipRanks’ unique ...
A new mRNA vaccine developed in Japan has been shown to suppress abnormal blood vessel growth in the retina of mice, offering hope to millions of patients with age-related vision loss.